课题基金 / 基金详情

Regulation of rejection against zenotransplantation by gene transfer of guinea pig species-specific complement regulatory molecules

Regulation of rejection against zenotransplantation by gene transfer of guinea pig species-specific complement regulatory molecules
通过豚鼠物种特异性补体调节分子的基因转移调节异种移植排斥反应
批准号:
09670234
负责人:
OKADA Noriko
金额:
$1.92万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

OKADA Noriko的其他基金

相似基金

相关文献

中文摘要
翻译
为了保护自身细胞膜上的补体激活,补体的膜抑制剂限制同种血清的补体激活(Okada等人)。1983年)。在异种移植中,调节供体器官补体的激活对克服超急性排斥反应非常重要。现已培育出表达人补体调节膜抑制因子的转基因猪,其中包括衰变加速因子(DAF)、膜辅助因子蛋白(MCP)和HRF2O(2OkDa同源限制因子),并用作猪到灵长类动物器官移植的模型。最近,为了在实验动物中鉴定调控分子,我们克隆了豚鼠(Gp)DAF和gpMCP以及大鼠512抗原(Rat Crry)和大鼠DAF和大鼠MCP的cDNA。此外,我们还分析了大鼠DAF和大鼠MCP的基因定位,表明小鼠MCP基因与远端染色体上的Cr2基因紧密连锁。gpDAF是由单一拷贝基因选择性剪接产生的多个异构体组成的。这些异构体主要由糖基磷脂酰肌醇锚定形式和跨膜形式组成,这些形式在人DAF中不存在。我们将这六种主要异构体的cDNA导入实验动物,并对其功能差异进行了评估,以选择最佳的候选基因导入实验动物。
英文摘要
To protect complement activation on self cell membranes, membrane inhibitors of complement restrict complement activation of homologous serum (Okada et al. 1983). In xenotransplantation, regulation of complement activation on donor organ is very important to overcome hyperacute rejection. Transgenic pigs that express human complement regulatory membrane inhibitors which include decay accelerating factor (DAF), membrane cofactor protein (MCP) and HRF2O (2OkDa homologous restriction factor), have been generated, and being used as models of transplantation of organs from pig to primates. Recently, for the purpose of identifying regulatory molecules among the experimental animals, we have cloned the cDNAs of guinea pig(gp) DAF and gpMCP, and rat 512 antigen (rat Crry) and rat DAF and rat MCP.Furthermore we also analyzed the gene orientation of rat DAF and rat MCP which shows close linkage between the mouse Mcp and Cr2 genes on distal chromosome 1.gpDAF consists of multiple isoforms generated by alternative splicing from a single copy gene. The isoforms are mainly comprised of a glycosylphosphatidylinositol anchored form and a transmenbrane form that are not present in human DAF.We have transfected cDNA of the six major isoforms and the functional differences were evaluated to choose the best candidate to transgene into the experimental animals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nangaku, M., et al.: "Overexpression of Crry protects mesangial cells from complement-mediated injury." J.Am.Soc.Nephrol.8. 223-233 (1997)
Nangaku, M. 等人:“Crry 的过度表达可保护系膜细胞免受补体介导的损伤。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Miwa, T., et.al.: "Molecular cloning of rat and mouse membrane cofactor protein (MCP, CD46) : preferential expression in testis and close linkage between the mouse Mcp and Cr2 genes on distal chromosome 1." Immunogenetics. 48. 363-371 (1998)
Miwa, T., et.al.:“大鼠和小鼠膜辅因子蛋白(MCP、CD46)的分子克隆:在睾丸中优先表达以及远端染色体 1 上的小鼠 Mcp 和 Cr2 基因之间的紧密连锁。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 49 条
    Novel Complementary Peptides Control Inflammatory Responses
    • 批准号:
      22659081
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $1.51万
    • 财政年份:
      2010
    • 负责人:
      OKADA Noriko
    • 依托单位:
    Development of transgenic animals of complement regulatory molecules.
    • 批准号:
      07557337
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $1.47万
    • 财政年份:
      1995
    • 负责人:
      OKADA Noriko
    • 依托单位:
    Studies on HRF 20, a novel membrane glycoprotein which restrict homologous complement reaction
    • 批准号:
      02670210
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $0.58万
    • 财政年份:
      1990
    • 负责人:
      OKADA Noriko
    • 依托单位:
    Studies on the membrane complement inhibitors by use of reconstituted liposome membrane
    • 批准号:
      60570231
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.02万
    • 财政年份:
      1985
    • 负责人:
      OKADA Noriko
    • 依托单位:
    国内基金
    海外基金
    糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
    • 批准号:
      82371634
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      赵福军
    • 依托单位:
    PRNP调控巨噬细胞M2极化并减弱吞噬功能促进子宫内膜异位症进展的机制研究
    • 批准号:
      82371651
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      赵栋
    • 依托单位:
    CBP/p300-HADH轴在基础胰岛素分泌调节中的作用和机制研究
    • 批准号:
      82370798
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      王晓
    • 依托单位:
    精氨酸调控骨髓Tregs稳态在脓毒症骨髓功能障碍中的作用研究
    • 批准号:
      82371770
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      宁铂涛
    • 依托单位: